TandemLife is now a part of LivaNova, Learn More Here.
COVID-19 UPDATES:The U.S. Food and Drug Administration (FDA) issued guidance on April 6, 2020 to temporarily expand the availability of devices used in extracorporeal membrane oxygenation (ECMO) therapy to address the novel coronavirus (COVID-19) public health emergency. As a result of the guidance, cardiopulmonary devices, including select devices from TandemLife | LivaNova, are now temporarily indicated for ECMO therapy greater than 6 hours. To read the full announcement, click here.
MENU
Contact
412 963 7770 GENERAL INFORMATION
855 336 3051 REIMBURSEMENT
24/7 Clinical Support
800 373 1607 US
412 507 6182 INTERNATIONAL
Life Support Simplified.
For more patients, in more places.
Introducing LifeSPARCTM, LivaNova’s next generation Advanced Circulatory Support System. Designed to help simplify temporary cardiopulmonary bypass so that more patients have access to this high level of support.
Empowering your program to deliver breakthrough performance in extracorporeal circulatory support.
The TandemHeart pump was the driving force behind the world’s first percutaneous left heart support system. With LifeSPARC, we’re adding to this legacy of innovation, by combining advanced technology and the product lines you’ve come to trust.
Speed & Simplicity.
The TandemLife Kit takes the complexity out of emergent rescue.
The TandemLife platform is a comprehensive circulatory support system that will enable you to initiate temporary, emergent cardiopulmonary bypass procedures with confidence.
TandemLife exists to provide innovative circulatory support products focused on improving patient outcomes and reducing healthcare costs. We develop, manufacture, and market novel medical devices to Healthcare Professionals.
LifeSPARC: In the U.S., the LifeSPARC system is intended to pump blood through an extracorporeal circuit for periods lasting less than six hours for the purpose of providing either: (i) full or partial cardiopulmonary bypass (i.e., circuit includes an oxygenator) during open surgical procedures on the heart or great vessels; or (ii) temporary circulatory bypass for diversion of flow around a planned disruption of the circulatory pathway necessary for open surgical procedures on the aorta or vena cava.
TandemHeart Controller: The TandemHeart Escort Controller is intended to be used with the TandemHeart System. The TandemHeart System consists of the TandemHeart Blood Pump, a single use, disposable device; the TandemHeart Escort (T.H.E.) Controller, a reusable control system for the TandemHeart Blood Pump; and disposable accessory items used in conjunction with the TandemHeart System.
TandemHeart Pump: The TandemHeart pump is intended to pump the blood through an extracorporeal circuit for periods lasting less than 6 hours for the purpose of providing either: (i) Full or partial cardiopulmonary bypass (i.e., circuit includes an oxygenator) during open surgical procedures on the heart or great vessels; or (ii) Temporary circulatory bypass for diversion of flow around a planned disruption of the circulatory pathway necessary for open surgical procedures on the aorta or vena cava.
TandemLung Oxygenator: The TandemLung Oxygenator is intended for use in an extracorporeal circuit requiring cardiopulmonary bypass for application duration limited to six hours. Within the specified flow rate range, the device oxygenates the blood and removes carbon dioxide from the blood. Responsibility for clinical application of the oxygenator rests solely with the attending physician.
ProtekSolo 62 and 72 cm Transseptal Cannulae: The Transseptal Cannula Set-EF is intended for transseptal catheterization of the left atrium via the femoral vein for the purpose of providing a means for temporary (six hours or less) left ventricular bypass when connected to the TandemHeart extracorporeal blood pump, which returns blood to the patient via the femoral artery or other appropriate site.
ProtekSolo Venous Cannula: The Venous Cannula and Obturator is intended to cannulate vessels, perfuse vessels or organs and/or connect with accessory extracorporeal circulatory support equipment. The cannula obturator is intended to facilitate proper insertion and placement of the cannula within the vessel for extracorporeal circulatory support. These devices are to be used by a trained physician only.
ProtekSolo 15 and 17 Fr Arterial Cannulae: The Femoral Arterial Cannula and Introducer are intended to cannulate vessels, perfuse vessels or organs, and/or connect with accessory extracorporeal circulatory support equipment for a duration of six hours or less. The cannula introducer is intended to facilitate proper insertion and placement of the cannula within the vessel for extracorporeal support. These devices are to be used by a trained physician only.
ProtekDuo 29 and 31 Fr and ProtekDuo RD 31 Fr Veno-Venous Cannulae: The ProtekDuo Veno-Venous Cannula Set is intended for use as a single cannula for both venous drainage and reinfusion of blood via an internal jugular vein during extracorporeal life support procedures.
VoyagerVest: The Voyager Vest is intended to provide secure attachment of Extracorporeal Life Support (ECLS) components (pump, oxygenator, and tubing) to the patient during cardiopulmonary bypass.
